Log in to save to my catalogue

A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or meta...

A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or meta...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_50528f52e68f48bfb46e1e410cc9fb90

A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis

About this item

Full title

A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis

Publisher

London, England: SAGE Publications

Journal title

Journal of international medical research, 2019-10, Vol.47 (10), p.4664-4672

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Objectives
To assess the efficacy and tolerability of cabazitaxel in relapsed penile cancer.
Methods
This Phase II single-arm trial was designed to recruit 17 patients with relapsed penile cancer. The primary endpoint was objective (complete + partial) response rate (ORR; Response Evaluation Criteria in Solid Tumours [RECIST] v1.1). Treatm...

Alternative Titles

Full title

A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_50528f52e68f48bfb46e1e410cc9fb90

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_50528f52e68f48bfb46e1e410cc9fb90

Other Identifiers

ISSN

0300-0605

E-ISSN

1473-2300

DOI

10.1177/0300060519863546

How to access this item